Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials

Christopher L. Hallemeier(Mayo Clinic in Arizona), Howard M. Sandler(Cedars-Sinai Medical Center), D.G. McGowan(Alberta Cancer Foundation), Seth A. Rosenthal(The University of Texas MD Anderson Cancer Center), Luís Souhami(McGill University Health Centre), Eric M. Horwitz(Fox Chase Cancer Center), S. Firat(Medical College of Wisconsin), Himanshu Lukka(Juravinski Cancer Centre), David D’Souza(London Cancer), Kenneth L. Zeitzer(Jefferson Einstein Philadelphia Hospital), Rebecca Paulus(NRG Oncology), Siraj Husain, Mack Roach(University of California, San Francisco), Peixin Zhang(NRG Oncology), Edward F. Miles(Dartmouth–Hitchcock Medical Center), Gerald E. Hanks(Fox Chase Cancer Center), Matthew Parliament(Alberta Cancer Foundation), Marvin Rotman(SUNY Downstate Health Sciences University), Thomas M. Pisansky(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
April 6, 2019
Cited by 13


Related Papers